Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanis Godwin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the Royal Society of New Zealand|August 4, 2025
Hereditary diffuse gastric cancer: the evolution of a cancer syndromeLyvianne Decourtye-Espiard, Tanis Godwin, Parry Guilford
Cancers|January 11, 2022
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle TraffickingTom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, et al.
Molecular Cancer|August 3, 2018
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancerJoana Figueiredo, Soraia Melo, Kimberley Gamet, et al.
Cancers|January 11, 2022
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC InhibitorsLyvianne Decourtye-Espiard, Nicola Bougen-Zhukov, Tanis Godwin, et al.
Cancers|April 12, 2022
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor DasatinibNicola Bougen-Zhukov, Lyvianne Decourtye-Espiard, Wilson Mitchell, et al.
Molecular Cancer Therapeutics|March 18, 2015
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient CellsBryony J Telford, Augustine Chen, Henry Beetham, et al.
Cancers|September 22, 2019
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient CellsNicola Bougen-Zhukov, Yasmin Nouri, Tanis Godwin, et al.
Gut|February 18, 2026
E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine modelLyvianne Decourtye-Espiard, Emily Schulpen, Kate McElroy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the Royal Society of New Zealand|August 4, 2025
Hereditary diffuse gastric cancer: the evolution of a cancer syndromeLyvianne Decourtye-Espiard, Tanis Godwin, Parry Guilford
Cancers|January 11, 2022
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle TraffickingTom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, et al.
Molecular Cancer|August 3, 2018
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancerJoana Figueiredo, Soraia Melo, Kimberley Gamet, et al.
Cancers|January 11, 2022
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC InhibitorsLyvianne Decourtye-Espiard, Nicola Bougen-Zhukov, Tanis Godwin, et al.
Cancers|April 12, 2022
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor DasatinibNicola Bougen-Zhukov, Lyvianne Decourtye-Espiard, Wilson Mitchell, et al.
Molecular Cancer Therapeutics|March 18, 2015
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient CellsBryony J Telford, Augustine Chen, Henry Beetham, et al.
Cancers|September 22, 2019
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient CellsNicola Bougen-Zhukov, Yasmin Nouri, Tanis Godwin, et al.
Gut|February 18, 2026
E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine modelLyvianne Decourtye-Espiard, Emily Schulpen, Kate McElroy, et al.
Pageof 1